William S. Meyer is a clinical social worker and psychoanalytic psychotherapist who holds faculty positions at Duke in the Departments of Psychiatry and Ob/Gyn. He has spent 20 years working with postpartum depression at the Duke Medical Center. In this interview, he discusses the role of psychotherapy, community, family, and where medications and the new neurosteroid brexanolone (Zulresso) fit in the big picture.
Publication Date: 8/26/19
Runtime: 15 minutes, 58 seconds
Articles Referenced: “Brexanolone: A New Treatment for Postpartum Depression, (https://www.thecarlatreport.com/the-carlat-psychiatry-report/brexanolone-a-new-treatment-for-postpartum-depression/)” The Carlat Psychiatry Report, January, 2019
"Brexanolone (Zulresso) for Postpartum Depression, (https://www.thecarlatreport.com/the-carlat-psychiatry-report/brexanolone-zulresso-for-postpartum-depression/)" The Carlat Psychiatry Report, June 2019

A New Treatment for Postpartum Depression

Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.    
Earn CME for listening at www.thecarlatreport.com/podcastcme

Alternative Health

Health

Medicine

Science & Medicine

Health & Fitness

Mental Health

In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options. CME: Take the CME Post-Test for this EpisodePublished On: 04/15/2024Duration: 30 minutes, 43 secondNoah Capurso, MD, Brian Hurley, MD have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Stimulant Update with Dr. Brian Hurley

Does psychiatry keep making the same mistakes? Edward Shorter gives us a historical perspective. CME: Take the CME Post-Test for this EpisodePublished On: 04/08/2024Duration: 22 minutes, 16 secondChris Aiken, MD, Edward Shorter, PhD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Controversies in Psychiatry

Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.CME: Take the CME Post-Test for this EpisodePublished On: 04/01/2024Duration: 12 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Viibryd Goes Generic

All sorts of medications are prescribed for anxiety in older adults. Today, we look at when and how to discontinue them.CME: Take the CME Post-Test for this EpisodePublished On: 03/25/2024Duration: 22 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Deprescribing Anti-anxiety Meds in Older Adults

Today we are discussing dissociative identity disorder (DID) and related topics ﻿﻿Published On: 03/18/2024Duration: 17 minutes, 31 secondsJoshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A New Treatment for Postpartum Depression

Download our free app to listen on your phone